Target Name: ZNF383
NCBI ID: G163087
Review Report on ZNF383 Target / Biomarker Content of Review Report on ZNF383 Target / Biomarker
ZNF383
Other Name(s): ZNF383 variant 4 | ZN383_HUMAN | Zfp383 | Zinc finger protein 383, transcript variant 4 | Zinc finger protein 383 | HSD17 | zinc finger protein 383

Introduction to ZNF383, A Potential Drug Target

ZNF383, also known as Zinc Finger Protein 383, is a protein that has gained considerable interest as a potential drug target or biomarker in various diseases. This article aims to provide an in-depth understanding of ZNF383, its functions, and its significance in the field of medicine and therapeutics.

Structure and Function

ZNF383 is a transcription factor that belongs to the Kr眉ppel-associated box (KRAB) zinc finger protein family. It contains multiple C2H2-type zinc finger domains, which are essential for its DNA-binding activity and regulation of gene expression. These zinc finger motifs help ZNF383 recognize specific DNA sequences and initiate transcriptional activation or repression of target genes.

Upon binding to its target DNA sequences, ZNF383 exerts its regulatory functions by recruiting co-repressors or co-activators to the target gene promoters. The repressive or activating signals trigger a cascade of events, leading to the modulation of downstream gene expression and subsequent cellular responses.

Role in Development and Cell Differentiation

ZNF383 plays a crucial role in the regulation of development and cell differentiation processes. Studies have shown that ZNF383 is highly expressed in embryonic tissues, contributing to the control of gene expression patterns during embryogenesis. It has been found to interact with key developmental transcription factors, thus modulating the fate determination of stem cells and progenitor cells.

Furthermore, ZNF383 is involved in the differentiation of several cell lineages, including neural cells, hematopoietic cells, and adipocytes. It acts as a transcriptional regulator that fine-tunes the expression of genes necessary for cell fate specification and proper tissue development.

ZNF383 in Disease

In recent years, ZNF383 has emerged as a potential biomarker and drug target in various diseases. Research has shown its dysregulation in several cancer types, including lung cancer, breast cancer, and colorectal cancer. In lung cancer, ZNF383 has been found to be upregulated and associated with tumor progression and poor prognosis. This suggests that targeting ZNF383 may hold promise for developing novel therapeutic strategies or diagnostic markers for cancer patients.

Furthermore, ZNF383 has also been implicated in autoimmune disorders, such as rheumatoid arthritis and systemic lupus erythematosus. In these conditions, aberrant expression or activity of ZNF383 has been associated with dysregulated immune responses and inflammatory processes. Targeting ZNF383 signaling pathways could potentially offer new therapeutic approaches for managing these debilitating conditions.

Therapeutic Potential of ZNF383

Given its involvement in various diseases, ZNF383 presents an attractive target for drug development. Researchers have explored different strategies to modulate its activity and evaluate its potential as a therapeutic intervention.

One approach involves the use of small molecule inhibitors that selectively bind to ZNF383 and interfere with its DNA-binding activity. By disrupting the interaction between ZNF383 and its target genes, these inhibitors could potentially alter gene expression patterns and halt disease progression.

Another avenue of research focuses on utilizing gene therapy techniques to manipulate ZNF383 expression levels. This approach aims to restore ZNF383 activity in cases where it is downregulated or to inhibit its function in diseases where it is overexpressed. Gene-editing technologies, such as CRISPR-Cas9, offer promising tools to precisely modulate ZNF383 expression and study its therapeutic effects in preclinical models.

Conclusion

ZNF383, a transcription factor belonging to the KRAB zinc finger protein family, plays a critical role in the regulation of gene expression, development, and cell differentiation. Its dysregulation has been implicated in various diseases, making it an attractive target for therapeutic interventions. Research efforts in understanding ZNF383's functions and developing strategies to modulate its activity are rapidly expanding, offering hope for new treatments and diagnostic tools in the future. Further studies are necessary to unravel the full potential of ZNF383 as a drug target or biomarker and transform this knowledge into clinical applications that benefit patients worldwide.

Protein Name: Zinc Finger Protein 383

Functions: May function as a transcriptional repressor, suppressing transcriptional activities mediated by MAPK signaling pathways

The "ZNF383 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF383 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF384 | ZNF385A | ZNF385B | ZNF385C | ZNF385D | ZNF385D-AS1 | ZNF385D-AS2 | ZNF391 | ZNF394 | ZNF395 | ZNF396 | ZNF397 | ZNF398 | ZNF402P | ZNF404 | ZNF407 | ZNF407-AS1 | ZNF408 | ZNF41 | ZNF410 | ZNF414 | ZNF415 | ZNF416 | ZNF417 | ZNF418 | ZNF419 | ZNF420 | ZNF423 | ZNF425 | ZNF426 | ZNF428 | ZNF429 | ZNF43 | ZNF430 | ZNF431 | ZNF432 | ZNF433 | ZNF433-AS1 | ZNF436 | ZNF436-AS1 | ZNF438 | ZNF439 | ZNF44 | ZNF440 | ZNF441 | ZNF442 | ZNF443 | ZNF444 | ZNF445 | ZNF446 | ZNF449 | ZNF45 | ZNF451 | ZNF454 | ZNF460 | ZNF461 | ZNF462 | ZNF467 | ZNF468 | ZNF469 | ZNF470 | ZNF471 | ZNF473 | ZNF473CR | ZNF479 | ZNF48 | ZNF480 | ZNF483 | ZNF484 | ZNF485 | ZNF486 | ZNF487 | ZNF488 | ZNF490 | ZNF491 | ZNF492 | ZNF493 | ZNF496 | ZNF497 | ZNF497-AS1 | ZNF500 | ZNF501 | ZNF502 | ZNF503 | ZNF503-AS1 | ZNF503-AS2 | ZNF506 | ZNF507 | ZNF510 | ZNF511 | ZNF512 | ZNF512B | ZNF513 | ZNF514 | ZNF516 | ZNF516-DT | ZNF517 | ZNF518A | ZNF518B | ZNF519